Pacific Bio (PACB) Tops Q3 EPS by 5c

Pacific Bio (NASDAQ: PACB) reported Q3 EPS of ($0.17), $0.05 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $40 million versus the consensus estimate of $41.95 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• Alamos Gold Inc. (AGI:CN) (AGI) PT Lowered to Cdn$73 at BMO Capital
• Neotech Metals closes $3.08M private placement